SPHS


Sophiris Bio (SPHS) Stock Suffers, But Bullish Analyst Sees Potential Ahead

Earlier this week, Sophiris Bio (SPHS) released data from its Phase 2b trial for Prostate Cancer medication called “Topsaylysin,” and it didn’t exactly …

Here’s Why Sophiris (SPHS) Stock Skyrockets Today

Sophiris (NASDAQ:SPHS) shares are shooting up 27% faster than Jack’s magic bean sparking right into a giant beanstalk. The reason?

Analyst Looks Beyond Sophiris Bio Inc (SPHS) Completed Phase 2b Enrollment to Large Opportunity Awaiting in Prostate Cancer Market

Maxim’s Jason Kolbert is betting on SPHS to “unlock” share value with prostate cancer asset topsalysin.

Sophiris Bio Inc. (SPHS) Shines Light on Topsalysin Phase 2b Enrollment in Localized Prostate Cancer

Sophiris Bio Inc (NASDAQ:SPHS) provided an update on clinical trial enrollment of its Phase 2b study of topsalysin as a treatment for men …

Sophiris Bio Inc (SPHS) Announces 2Q:17 Results and Provides Corporate Update

Sophiris Bio Inc (NASDAQ:SPHS) reported financial results for the three and six months ended June 30, 2017 and key corporate highlights. Key Corporate Highlights: Phase …

Sophiris Bio Inc (SPHS): Phase 2b Trial One Step a Way to Take Off

Drug maker Sophiris Bio Inc (NASDAQ:SPHS) released its earnings report for the first quarter of 2017 and is one step closer to beginning Phase …

Sophiris Bio Inc (SPHS) Announces Q1:17 Financial Results

  Sophiris Bio Inc (NASDAQ:SPHS) reported first quarter financial results and key corporate highlights. Key Corporate Highlights: Update on Phase 2b Localized Prostate …

Sophiris Bio Inc (SPHS): Prostate Cancer Drug Continues To Impress

Following Sophiris Bio Inc’s (NASDAQ:SPHS) fourth-quarter and 2016 financial results released yesterday coupled with last week’s update on its prostate cancer program, Rodman …

4Q Update: Sophiris Bio Inc (SPHS) Gets A Buy From Maxim

Maxim analyst Jason Kolbert was out with a research note on Sophiris Bio Inc (NASDAQ:SPHS), following the company’s fourth-quarter financial results and update on its …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts